Literature DB >> 21707506

Impact of oncogenic protein tyrosine phosphatases in cancer.

Serge Hardy1, Sofi G Julien, Michel L Tremblay.   

Abstract

Protein tyrosine phosphatases (PTPs) constitute a large family of enzymes that can exert both positive and negative effects on signaling pathways. They play dominant roles in setting the levels of intracellular phosphorylation downstream of many receptors including receptor tyrosine kinases and G protein-coupled receptors. As observed with kinases, deregulation of PTP activity can also contribute to cancer. This review will examine a broad array of PTP family members that positively affect oncogenesis in human cancer tissues. We will describe the PTP family, their biological significance in oncology, and how recent progress is being made to more effectively target specific PTPs. Finally, we will discuss the therapeutic implications of targeting these oncogenic PTPs in cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21707506     DOI: 10.2174/187152012798764741

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  13 in total

1.  A missense methionine mutation augments catalytic activity but reduces thermal stability in two protein tyrosine phosphatases.

Authors:  Anthony C Bishop
Journal:  Biochem Biophys Res Commun       Date:  2016-11-02       Impact factor: 3.575

2.  Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases.

Authors:  Cynthia M Chio; Xiaoling Yu; Anthony C Bishop
Journal:  Bioorg Med Chem       Date:  2015-03-17       Impact factor: 3.641

3.  Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.

Authors:  Paula Giménez-Mascarell; Iker Oyenarte; Serge Hardy; Tilman Breiderhoff; Marchel Stuiver; Elie Kostantin; Tammo Diercks; Angel L Pey; June Ereño-Orbea; María Luz Martínez-Chantar; Reham Khalaf-Nazzal; Felix Claverie-Martin; Dominik Müller; Michel L Tremblay; Luis Alfonso Martínez-Cruz
Journal:  J Biol Chem       Date:  2016-11-29       Impact factor: 5.157

4.  Optimized allosteric inhibition of engineered protein tyrosine phosphatases with an expanded palette of biarsenical small molecules.

Authors:  Samuel Korntner; Adam Pomorski; Artur Krężel; Anthony C Bishop
Journal:  Bioorg Med Chem       Date:  2018-04-12       Impact factor: 3.641

5.  High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design.

Authors:  George T Lountos; Sreejith Raran-Kurussi; Bryan M Zhao; Beverly K Dyas; Terrence R Burke; Robert G Ulrich; David S Waugh
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

6.  PRL2 links magnesium flux and sex-dependent circadian metabolic rhythms.

Authors:  Noriko Uetani; Serge Hardy; Simon-Pierre Gravel; Silke Kiessling; Adam Pietrobon; Nau Nau Wong; Valérie Chénard; Nicolas Cermakian; Julie St-Pierre; Michel L Tremblay
Journal:  JCI Insight       Date:  2017-07-06

Review 7.  Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

Review 8.  Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma.

Authors:  Mariana Tannús Ruckert; Pamela Viani de Andrade; Verena Silva Santos; Vanessa Silva Silveira
Journal:  Cell Mol Life Sci       Date:  2019-04-13       Impact factor: 9.207

9.  Targeting a cryptic allosteric site for selective inhibition of the oncogenic protein tyrosine phosphatase Shp2.

Authors:  Cynthia M Chio; Christopher S Lim; Anthony C Bishop
Journal:  Biochemistry       Date:  2015-01-02       Impact factor: 3.162

Review 10.  In Silico Logical Modelling to Uncover Cooperative Interactions in Cancer.

Authors:  Gianluca Selvaggio; Claudine Chaouiya; Florence Janody
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.